Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,060 | 2 | 66.5% |
| Travel and Lodging | $622.47 | 2 | 20.1% |
| Food and Beverage | $314.72 | 11 | 10.2% |
| Education | $99.00 | 1 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Puma Biotechnology, Inc. | $2,846 | 7 | $0 (2018) |
| Pharmacyclics LLC, An AbbVie Company | $133.35 | 7 | $0 (2017) |
| COMSORT, Inc | $100.00 | 1 | $0 (2019) |
| Novocure Inc. | $16.71 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $100.00 | 1 | COMSORT, Inc ($100.00) |
| 2018 | $2,863 | 8 | Puma Biotechnology, Inc. ($2,846) |
| 2017 | $133.35 | 7 | Pharmacyclics LLC, An AbbVie Company ($133.35) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/01/2019 | COMSORT, Inc | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $100.00 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2018 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $16.71 | General |
| Category: Optune | ||||||
| 06/22/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Consulting Fee | Cash or cash equivalent | $1,960.00 | General |
| Category: Oncology | ||||||
| 06/22/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Travel and Lodging | Cash or cash equivalent | $422.32 | General |
| Category: Oncology | ||||||
| 06/22/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Travel and Lodging | Cash or cash equivalent | $200.15 | General |
| Category: Oncology | ||||||
| 06/22/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $112.73 | General |
| Category: Oncology | ||||||
| 06/22/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $53.69 | General |
| Category: Oncology | ||||||
| 06/22/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $52.03 | General |
| Category: Oncology | ||||||
| 06/22/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $45.21 | General |
| Category: Oncology | ||||||
| 12/21/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Oncology | ||||||
| 12/21/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $4.13 | General |
| Category: Oncology | ||||||
| 10/19/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $7.05 | General |
| Category: Oncology | ||||||
| 07/20/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: Oncology | ||||||
| 05/18/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: Oncology | ||||||
| 04/20/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: Oncology | ||||||
| 02/16/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $3.31 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 104 | 141 | $22,346 | $10,446 |
| 2022 | 3 | 71 | 118 | $21,846 | $10,733 |
| 2021 | 1 | 22 | 24 | $3,960 | $2,370 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 44 | 64 | $9,085 | $4,608 | 50.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 47 | $9,306 | $4,276 | 46.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 18 | 19 | $2,427 | $890.82 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $1,529 | $670.40 | 43.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 77 | $14,652 | $7,063 | 48.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 15 | $3,769 | $2,048 | 54.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 26 | $3,425 | $1,622 | 47.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 24 | $3,960 | $2,370 | 59.9% |
About Dr. Harvey Zimbler, M.D
Dr. Harvey Zimbler, M.D is a Hematology & Oncology healthcare provider based in Pittsfield, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083686224.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harvey Zimbler, M.D has received a total of $3,096 in payments from pharmaceutical and medical device companies, with $100.00 received in 2019. These payments were reported across 16 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($2,060).
As a Medicare-enrolled provider, Zimbler has provided services to 197 Medicare beneficiaries, totaling 283 services with total Medicare billing of $23,549. Data is available for 3 years (2021–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Pittsfield, MA
- Active Since 02/02/2006
- Last Updated 09/28/2011
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1083686224
Products in Payments
- Nerlynx (Drug) $2,846
- Imbruvica (Drug) $133.35
- KEYTRUDA (Biological) $100.00
- Oncology (Device) $16.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Pittsfield
Michael Deleo, M.d, M.D
Hematology & Oncology — Payments: $297.39
Spyridon Triantos, M.d, M.D
Hematology & Oncology — Payments: $90.69
Paul Rosenthal, M.d, M.D
Hematology & Oncology — Payments: $41.85
Jesse Spector, M.d, M.D
Hematology & Oncology